Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement in Men With Opioid-Induced Hypogonadism
NCT04798469Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2022
- Primary completion
- Sep 2027
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone undecanoate in Hypogonadism, sponsored by Brigham and Women's Hospital. Started Jan 2022; status: recruiting.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT04798469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04798469.